Oral glucose tolerance was tested in a heterogeneous group of 108 patients with liver cirrhosis. Data were compared with those from 181 subjects without liver disease (44% normal, 35% impaired glucose tolerance and 21% type 2 diabetes mellitus). In cirrhosis, 27% of the patients had normal, 36% had impaired glucose tolerance, and 37% were diabetic. There was no association between glucose intolerance or diabetes and the aetiology of cirrhosis, the duration of the disease* the biochemical indicators of hepatocyte damage, cholestasis and/or liver ftmction. Only weak associations were found between the results of quantitative liver functions tests (caffeine, xylocaine®, indocyanine green) and basal and post load glucose and insulin concentrations. Cirrhotics with Ist degree relatives with type 2 diabetes mellitus (n = 16) did not show an increased prevalence of diabetes. Older and/or malnourished patients were more frequently glucose intolerant. Using the plasma glucose concentration 120 minutes after glucose load äs the dependent variable, multivariate regression analysis showed that 54% of its variance is assqciated with the following variables: basal plasma glucose (36%) and free fatty acid concentration (5%), age (3%), basal glucose oxidation rate (3%), muscle mass (3%) and plasma free glycerol at 120 minutes after glucose load (3%). By contrast, the clinical state of the patients (i. e. the CHILD-PwgA score) accounted for only 2% of the variance. We conclude that glucose tolerance is variable in cirrhosis. After manifestation of liver disease, glucose intolerance or diabetes cannot be explained by the clinical, histological or biochemical signs of liver disease.
Introduction
number of questions remain unresolved. First, a considerable number of cirrhotic patients do not show maniLiver cirrhosis is frequently associated with secondary ^ disturbances in glucose me tabolism and it is unclear l diabetes, and about 50-80% of the patients show glu-whetfaer glucose intolerance or even diabetes ai wa ys deeose intolerance. Övert diabetes is found in 10 to 30% yelops with advanced liver disease . Second, the possible | of the patients and is two to four times more prevalent contr ib u tion of different aetiologies of cirrhosis has to ! than in the genefal population (l -4). Most authors con-be taken into acc ount, since insulin may exert different | sider an increased systemic appearance of glucose and m etabolic effects in different subgroups of patients (5) . insulin to be the primary abnormality. Peripheral hyper-Furthermore, the impact of sex, age and the duration of insulinaemia and postprandial hyperglycaemia then the disease, are not known. Third, individual patients at cause insulin resistance. Tbis scenario partly resembles high risk of developing diabetes mellitus (i. e. patients the chain of events known from type 2 diabetic patients with Ist degree relatives with diabetes mellitus) have to i (non-insulin dependent diabetes mellitus). Although nü-be considered separately. Fourth, the nutritional state is j , merous studies have been performed in this area, a frequently reduced and about 70% of patients with cir-rhosis shovv some signs of malnutrition (6) (7) (8) . Surprisingly, most studies try to ensure that there is no nutritional difference between patients and controls. Malnutrition is known to contribute to insulin resistance in diabetic patients (9) and also to some metabolic alterations observed in cirrhosis (10, 11) .
The present study was performed on 108 patients with liver cirrhosis. Age, sex, the aetiology of cirrhosis, the duration of disease, hepatocyte damage, cholestasis, liver function and splanchnic circulation, a possible family history of diabetes mellitus and the nutritional state äs assessed by body composition analysis were all investigated and taken into account. Data were compared with those of 80 normal controls, 63 subjects with impaired glucose tolerance and 38 patients with non-insulin dependent diabetes mellitus.
Methods

Patients and study design
Patients with liver cirrhosis (n = 108) were investigated and compared retrospectively with a control group of 181 subjects with normal liver function and no history of liver and endocrine diseases. None of the cirrhotic patients had overt diabetes mellitus before manifestation of the liver disease. The control group consisted of 80 subjects with normal and 63 with impaired glucose tolerance. 38 subjects had non-insulin dependent diabetes mellitus.
The biological and physical characteristics of the different groups are given in table l. All patients were in a stable clinical condition. They were admitted to the Medizinische Hochschule Hannover between October 1989 and December 1990, because they were considered äs potential candidates for elective liver transplantation. An intensive clinical and laboratory assessment was performed within a 2 to 3 week period (12) . On examination all patients had a weight-maintaining diet including 200 g carbohydrates and a protein content of at least 0.8 g/kg body weight per day for l week before the glucose tolerance test. All drugs known to affect glucose metabolism were withdrawn at least 24 hours before the glucose tolerance test. The clinical classification was based on the plasma concentrations of bilirubin and albumin, the prothrombin time and the occurrence of ascites, and clinical signs of encephalopathy (i. e. the CHILD-Pwg/z score (13)). Moderate (< 2.51) or severe (> 2.5 1) volumes of ascites were found by ultrasound investigation in 44 and 19% of the patients, respectively. An oral glucose tolerance test (glucose load l g/kg body weight; l g glucose + 4 ml H 2 O) was performed at 8.00 a. m. after an overnight fast. Blood was collected through a butterfly needle introduced into an antecubital vein. Samples were drawn before and 60 and 120 minutes after the oral glucose load. Aliquots were transferred into different tubes placed on ice for the determination of plasma glucose, insulin, C-peptide, lactate, free fatty acids, free glycerol and ß-hydroxybutyrate.
Assessment of liver function
Liver function was assessed by Standard biochemical tests, äs well äs by the use of quantitative tests of liver function (8, 12, 14) . Indocyanine green (0.5 mg/kg body weight), caffeine (3 mg/kg body weight) and xylocaine (l mg/kg body weight) were injected intravenously on different occasions. The formation of the lidocaine metabolite, monoethylglycinexylidide was measured 15 minutes after xylocaine® injection (15) .
Assessment of the nutritional and metabolic state Nutritional state was assessed by Standard anthropometric procedures (triceps skinfolds and mid-arm circumference), the measurement of 24-hour urinary creatinine excretion äs an estimate of skeletal muscle mass and bioelectrical impedance analysis, using a radiofrequency current of 800 A at a 50-kHz frequency betweeii a set of electrodes attached to the.dorsum of the hand and foot (Akern, RJL body composition analyser, Data Input, Frankfurt, Germany (8, 12) ). In addition, total body potassium was determined in a sübgroup of 26 patients in a whole body counter with a precision of 2% (8) . Figure l shows a clpse association between body cell mass derived from total body potassium and bioelectrical impedance analysis. This is unaffected by the presence of ascites. However the accuracy of bioelectrical impedance analysis has been questioned in cirrhotic patients with ascites (16) . In contrast, paracentesis has only minor effects on bioelectrical impedance analysis data (8) . This is because different Segments of the body differently contribute to whole body resistance, e. g. the arm contributes äs much äs 45% but the tfunk is responsible for only 11% of whole body resistance (17) . Therefore several litres of ascites have only minor effects on whole body bioelectrical impedance analysis.
Resting energy expenditure was assessed after an overnight fast following the procedural issues described elsewhere (18) , using an indirect calorimeter (Deltatrac Metabolic Monitor, Datex Instruments, Helsinki Finland).
Laboratory rnethods !j
Enzymes, Substrates and hormones were assessed using Standard jj biochemical or radioimmünological procedures äs previoüsly der !' scribed (8, 12, 19 Eur. J. Clin. Chem. Clin. Biochem. / Vol. 32,1994 / Nö. 10 between respective quantities were calculated and processed by factor analysis and subsequent varimax rotation. In addition, the plasma glucose and Insulin concentrations at 120 minutes after glucose load (dependent variables) and their possible determinants (plasma concentrations of measured hormones and metabolites, age, sex, body composition indicators, liver function, CHlLD-Pugh score, plasma Substrate and hormone concentrations and basal substrate oxidation rates) were subjects in a stepwise regression analysis.
Results
The biological and physical characterisation of the study population is given in table 1. Subjects and patients with normal glucose tolerance were younger than those with impaired glucose metabolism. In addition, the mean age of a small subgroup of patients with Budd-Chiari syndrome was lower than the age of the other subgroups. Twenty-seven percent of patients with liver cirrhosis and 44% of the control group showed normal glucose tolerance; 36 and 35% had impaired glucose tolerance, whereas 37 and 21% were diabetic, respectively (flg. 2). The frequency of impaired glucose tolerance was of the same order of magnitude in all groups of cirrhotic patients (21-57%, tab. 2). Glucose intolerance and also diabetes mellitus were associated with basal and postTab. l Biological and physical characterization of the study population. Basal and postprandial hyperinsulinaemia were also observed in the diabetic control group and in subjects with impaired glucose tolerance (basal plasma insulin: 8.6 ± 4.3, 11.1 ± 5.2* and 15.7 ± 8.7 mU/1* in healthy controls, 'subjects with impaired glucose tolerance and patients with type 2 diabetes mellitus, respectively; *denotes significant differences versus controls, p < 0.05).
Control group
The corresponding values 120 minutes after glucose load were 58.2 ± 39.7, 150 ± 124* and 148 ± 124 mU/1*, respectively.
Basal free fatty acids (0.83 ± 0.40, 0.91 ± 0.42 and 1.07 ± 0.34 mmol/1*) and basal free glycerol plasma concentrations (0.13 ±0.04, 0.14 ±0.05 and 0.16 ± 0.04 mmol/1*) were increased in diabetic patients with liver cirrhosis when compared with those with normal or impaired glucose tolerance (*p < 0.05). However, postprandial (120 minutes after glucose load) plasma concentrations of free fatty acids (0.14 ± 0.05, 0.12 ± 0.12 and 0.15 ± 0.11 mmol/1) and of free glycerol (0.10 ± 0.05, 0.09 ± 0.04 and 0.09 ± 0.04 mmol/1) showed no significant differences between these subgroups of patients. Plasma ß-hydroxybutyrate concentrations decreased but lactate levels increased after the glucose load in patients with liver cirrhosis (data not shown). However, no significant differences were observed between the different subgroups of patients.
Biochemical tests of liver fimction, äs well äs quantitative liver fttnction tests, all deteriorate with deterioration of the clinical state (tab. 3). In contrast, there was no clear picture in subgroups of patients with different degrees of glucose intolerance. However, alanine aminotransferase 1 ) and albumin were both decreased in the diabetic group (tab. 3). The clearance rates of indocyanine green and caffeine were impaired in diabetic cir-
Alanine aminotransferase: L-Alanine : 2-oxoglutarate aminotransferase(EC2.6.1.2) rhotics with no difference in xylocaine® metabolisrh (tab. 3). Regression analysis showed significant correlations between the plasma glucose concentrations at 120 minutes, the half lives of caffeine (r = 0.28, p < 0.01) and indocyanine green (r = 0.22, p < 0.05), and the appearance of monoethylglycinexylidide at 30 minutes after injection of xylocaine® (r -0.21, p < 0.05). Basal and postprandial (120 minutes after glucose load) plasma insulin concentrations were correlated with the half life of indocyanine green (r = 0.38, p < 0.001 and r = 0.22, p < 0.05, respectively). No significant differences in the 120 minute plasma glucose and insulin concentrations were found (i) between CHILD A, B and C patients, (ii) patients with different durations of the disease, and (iii) patients with increased vs. normal ammonia and/or methioriine levels (data not shown).
Seventy-two percent of the patients had basal insulin concentrations of less than 20 mU/1 serum (mean values: 9.3 ± 3.5 mU/1) and 28% were considered äs hyperinsulinaemic (i. e. basal plasma insulin levels > 20 mU/1; mean: 31.9 ± 3.7 mU/1; p < 0.001). Differences in basal insulin concentrations were associated with differences in postprandial (120 minutes after glucose load) insulin concentrations (114 ± 87 and 202 ± 90 rnU/1 for basal insulin levels < 20 and > 20 mU/1, respectively; p < 0.01). Significant correlations were.observed·be-tween basal insulin concentrations and basal glucose (r = 0.43, p < 0.001), glucose at 120 minutes after glucose load (r = 0.23, p < 0.05) and insulin at 120 minutes after glucose load (r = 0.47, p < 0.001). In both the control and the cirrhotic group, plasma insulin levels progressively increased with fasting and postprandial (120 minutes after glucose load) glucose concentrations ( fig. 4) . Maximal plasma insulin concentrations were attained at a plasma glucose level of about 8 mmol/1 (tfig. 4). Thereafter, fürther increases in glucose were associated with decreases in insulin secretion. The insulin re^· sponse curve to an oral glucose load (i. e. plasma glucose vs. plasma insulin at 120 minutes after glucose load) was similar in patients with liver cirrhosis when compared with the data obtained in our control group 4).
No differences in the mean values of the different indicators of the nutritional and metabolic state were found between cirrhotics with different glucose tolerance curves (tab. 4). The plasma glucose concentration at 120 minutes after glucose load was significantly lower in male patients with normal body cell or muscle mass (10.5 ± 4.1 and 9.2 ± 3.1 mmol/1*; plasma insulin concentrations: 113 ± 70 and 170 ± 111 mU/1* for a muscle mass < 25 versus > 25 kg, respectively; *p < 0.05). No significant differences in ghicose tolerance curves were obtained for femajes differing with respect to muscle mass (plasma glucose at 120 minutes after glucose load 9.1 ±3.4 and 10.9 ±3.9 mmol/1; plasma insulin eoncentration 111 ±83 and 161 ± 109 mU/1* for a muscle mass < 16 vs. > 16 kg, respectively; *p < 0.05). There was no association between the plasma glucose concentration at 120 minutes after gluĉ ose load and whole body potassk n concentration, either expressed in absolute numbers or s K + concentration in mmol/1 body water ( s determined by bioetectrical impedance analysis) (r = 0.28 or 0.29, n. s., n = 26; data not shown). Patients with increased fat mass or obesity did not show an increased frequency of glucose intolerance (data not shown). A significant correlation was found between the plasma insulin concentration at 120 minutes after glucose load and fat mass (r = 0.43, p < 0.001). Comparison of subgroups with increased fat mass ( fig. 5 ) revealed no significant differences in the mean postprandial (120 minutes after glucose load) insulin and glucose responses between controls with impaired glucose tolerance or diabetes with and without obesity. At the same time there was a disproportional and significantly increased postprandial (120 minutes after glucose load) insulin response in obese patients with liver cirrhosis, when compared with patients with impaired glucose tolerance or diabetes alone ( fig. 5) . Concomitantly, obese and non-obese patients showed similar postprandial (120 minutes after glucose load) plasma glucose concentrations.
There were no significant differences between male and female patients. Regarding the possible contributory factor of age, glucose intolerance and also diabetes mellitus were more frequently seen at advanced age in patients with liver cirrhosis s well s in our control group ( fig. 6 ). This was independent of the duration of the disease. A family history of diabetes mellitus was obtained in 58 patients with liver cirrhosis. Twenty-eight percent of these patients had a positive family history (i. e. at least one Ist degree relative with diabetes mellitus type 2). Although patients with cirrhosis and an increased risk of becoming diabetic showed increased postprandial (120 minutes after glucose load) hyperinsulinaemia (n. s.), the relative frequency of diabetes mellitus was not increased in this subgroup.
Factor analysis with subsequent varimax rotation resulted in 9 factors (factor loading is given in brackets). In addition to varimax analysis, two stepwise multivariate regression analyses were performed. First, using the plasma glucose concentration at 120 minutes after glucose load s the dependent variable, about 54% of its variability could be explained by the quantities tested; the following r 2 values were obtained: 0.36 for basal glucose concentration, 0.05 for basal free fatty acid levels, 0.04 for age, 0.03 for basal glucose oxidation, 0.03 for muscle mass, 0.03 for plasma free glycerol levels at 120 minutes after glucose load and 0.02 for the CHILD score. Second, using the serum insulin concentration at 120 minutes after glucose load about 35% of its variance could be explained by the quantities tested; the following r^ values were obtained: 0.18 for basal serum insulin concentration, 0.09 for fat mass, 0.05 for muscle mass and 0.04 for the plasrna glucose concentration at 120 minutes after glucose load.
Discussion
Glucose intolerance is frequently seen in cirrhotic patients. Thirty-six percent of our patients had impaired glucose tolerance and 37% were diabetic ( fig. 1) . However, 27% of the patient group had normal glucose tolerance c rves ( fig. 1) . The reasons for this variance of glucose metab lism observed in cirrhosis are unclear. Our cross-sectional st dy addresses a number of factors considered to be important for the clinical characterisation of patients with liver cirrhosis. Stepwise regression analysis suggests that the aetiology and duration of cirrhosis, the clinical state, biochemical indicators of hepatocyte damage and/or liver function are of minor importance for glucose tolerance after the manifestation of the disease (see results). This does not contradict the idea that postprandial (120 minutes after glucose load) glucose concentrations may be inoreased in subgroups of patients with a more pronou ced reduction of liver function, s assessed by the use of quantitative liver function tests (tab. 3). However, the prevalenee of glucose .intolerance does not regularly increase with deteriorating clinical state (tab. ') (muscle arm circumference -3.14 X triceps skinfold thickness/ 4 X 3.14)-10 (male) or -6.5 (female) (according to (26)) 2 ) calculated from 7.38 + 0.029 X 113.2 X (24h urinary creatinine excretion in mmol/d) (according to 1. c. (22) and (26)) 3 ) calculated from data obtained by bioelectrical impedance analysis (see 1. c. (17, 20) ) 4 ) fraction of resting energy expenditure, % 5 ) calculated äs given in 1. c. (12) liver function are independent of the nutritional and metabolic quantities tested (see results). Impaired glucose tolerance is also seen in patients with acute viral Hepatitis (20) (21) (22) (23) , in a patient with presinusoidal portal hypertension (24) and in patients with fatty liver (25) without histological signs of liver cirrhosis. These findings suggest that liver injury and/or altered hepatic circulation, but not cirrhosis itself, are the initiating events of glucose intolerance. Interestingly, cirrhotics with a normal glucose tolerance do not develop glucose intolerance within the subsequent 5 years of observation (25) .
Although glucose intolerance is not associated with the clinical markers of liver disease, it is associated with metabolic factors, such äs basal plasma glucose concentrations, basal glucose oxidation rate and plasma free glycerol concentrations at 120 minutes after glucose load. Obviously these factors are for the most part other markers of the metabolic distürbance and thus cannot be considered äs causative. Malnutrition (i. e. a reduced muscle rnass) also reached significance'in our stepwise regfession analysis (see results). This is in line with previpus data, shpwirig that reduced muscle mass is associated with a reduced glucose disposal, using the euglycaemic-hyperiüsulinaemic clamp technique or the minimal model assessment in smaller groups of cirrhotics (10, 12) . With regard to changes in bpdy composition, some patients with cirrhosis show an increased fat mass ( fig. 5 ). These patients are markedly hyperinsulinaemic ( fig. 5) . A close association was foünd between postprandial (120 minutes after glucose load) hyperinsulinaemia and fat mass in cirrhotic patients (see results).
Although not conclusive, these data support our hypothesis that hyperinsulinaemia contributes to changes in body composition in patients with liver cirrhosis (26).
Advanced age is also known to increase the prevalence of glucose intolerance and non-insulin dependent diabetes mellitus in most populations (27) . This is also true in cirrhotic patients ( fig. 6 ). Prevalence represents the balance between the development of new cases and the effect of mortality among those with diabetes mellitus. Since longitudinal studies are lacking, one has to consider the possibility that the occurrence of cirrhosis plus diabetes mellitus may affect the mortality of patients with cirrhosis. However, it is unlikely that the occurrence of diabetes mellitus plus cirrhosis significantly reduces mortality. We therefore take our data äs evidence that advanced age contributes to the manifestation of glucose intolerance and diabetes mellitus in cirrhotic patients ( fig. 6 ).
liiere is a close association between plasma glucose and plasma Insulin levels in patients with cirrhosis, äs well äs in controls, showing an increase in insulin concentration with increasing glucose concentration up to a plasma glucose level of 8 to 10 mmol/1 ( fig. 4) . This association has been described äs the "Starling curve" of the pancreas (28) . Obviously, this mechanism is operative in cirrhotic and non-cirrhotic subjects. Plasma insulin levels are higher in cirrhotic thän in non-cirrhotic subjects over the whole ränge of plasma glucose concen- for type 2 diabetes mellitus are prone to develop glucose intolerance with the manifestation of liver disease. However, patients with a positive family history of diabetes mellitus do not show an increased frequency of glucose intolerance (see results). These data provide evidence for the idea that diabetes mellittis associated with liver cirrhosis is unrelated to non-ins lin dependent diabetes mellitus. Further evidence for this idea comes from a number of experimental and clinical studies (11, (34) (35) (36) (37) . In contrast to patients with non^insulin dependent diabetes mellitus, cirrhotics only show peripheral, but not hepatic insulin resistance (35, 38) . Peripheral insulin resistance in cirrhosis is characterised by decreased glucose transport (37) and reduced glycogen synthesis in skeletal muscle (33) (34) (35) (36) , whereas the insulin-induced increases in glucose phosphorylation (37), glycolysis (11) and glucose oxidation (34, 35, 38) trations. It is tempting to speculate that the increased insulin response seen in cirrhosis results from increased insulin secretion plus decreased hepatic insulin extraction (10, (29) (30) (31) . The contribution of these two quantities is variable and differs between different patients. The insulin/C-peptide ratio is a rough measure of portoŝ ystemic shunting of insulin, but can also be used under steady state conditions (i. e. in the basal state) in cirrhosis (30; fig. 2 ). Our data suggest an increased portosystemic shunting of insulin in the majority of cirrhotic patients. Concomitantly, insulin secretion seems to be normal or enhanced s reflected by plasma Opeptide levels ( fig. 2 ).
Secondary diabetes observed in liver diseases is considered to be an acquired phenomenon (32) . It is tempting to speculate that cirrhotics with a genetic predisposition 40). Marked hyperinsulinaemia normalises glycogen synthesis and the total flux through glycolysis, but does not restore a normal distribution between glucose oxidation and anaerobic glycolysis in diabetic subjects (40) . In cirrhosis, pharmacological amounts of insulin are not capable of normalising glycogen synthesis but they disproportionally increase lactate production (11) . Thus, when comparing non-insulin dependent diabetes mellitus with cirrhosis, considerable differences in the metabolic picture are obvious.
The variance in oral glucose tolerance observed in cirrhosis differs from the data obtained in clamp studies, in which the majority if not all cirrhotics show peripheral insulin resistance. To explain the different results, a number of influences have to be discussed. First, compensatory increases in insulin secretion may compensate for peripheral insulin resistance, resulting in a normal oral glucose tolerance curve in some cirrhotics (30) . Second, during a clamp study, skeletal muscle is responsible for 60 to 85% of whole body glucose disposal in controls, patients with non-insulin dependent diabetes mellitus (28) and in cirrhosis (37) . However, muscle accounts for only 25% of glucose disposal after an oral glucose load, while storage in muscle accounts for less than 10% of the load (41) . Thus, defective glucose storage probably plays a small role in the overall disposal of an oral glucose load. Third, differences in first pass hepatic uptake of glucose are of minor importance during an euglycaemic clamp study.
